Crossmark

Initiating antiretroviral therapy within 2 weeks of anti-Pneumocystis treatment does not increase mortality or AIDS-defining events in patients with HIV-associated moderate to severe Pneumocystis pneumonia: results of a prospective observational multicenter study

Crossref DOI link: https://doi.org/10.1186/s12890-022-02118-4

Published Online: 2022-08-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zeng, Yan-Ming

Li, Yao

Lu, Yan-Qiu

Liu, Min

Nie, Jing-Min

Yuan, Jing

Harypursat, Vijay

Zhou, Yi-Hong

Qin, Yuan-Yuan

Chen, Xiao-Hong

Zhang, Yu-Lin

Zhang, De-Fa

Wang, Ni

Chen, Hui

Tian, Qun

Zhou, Yang

Qin, Ying-Mei

Yang, Xin-Ping

Chen, Yao-Kai
License Information

Text and Data Mining valid from 2022-08-25

Version of Record valid from 2022-08-25
More Information

Article History

Received: 11 December 2021

Accepted: 18 August 2022

First Online: 25 August 2022

Declarations

:

: The study was approved by the ethics committee of the Chongqing Public Health Medical Center (2019–003-02-KY). All participants gave written informed consent to participate in this study. All methods were carried out in accordance with relevant guidelines and regulations.

: Not applicable.

: The authors declare that this research was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest.

Document is current

Any future updates will be listed below